Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification

This study highlights the importance of considering both clinical and molecular factors in the management of glioma patients to improve cognitive outcomes.
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research